COURTNEY PAPP: Open Payments
NPI 1912942285 · WAUKESHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 55 payments from 16 companies in 2025. Trend: 2023 $710 · 2024 $592 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $177 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $155 |
| GENZYME CORPORATION | 6 | $135 |
| Organon LLC | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| PFIZER INC. | 3 | $68 |
| Amgen Inc. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $34 |
Products named: DUPIXENT, SKYRIZI, ILUMYA, RINVOQ, OTEZLA, NEXPLANON, BLU-U, CIBINQO.
Industry payments across WI — which companies pay providers there.
